Ticker >

Indegene share price

Indegene Ltd.

NSE: INDGN BSE: 544172 SECTOR: Pharmaceuticals & Drugs  47k   29   8

676.50
+21.70 (3.31%)
NSE: Today, 01:14 PM

Price Summary

Today's High

₹ 680.9

Today's Low

₹ 647

52 Week High

₹ 736.3

52 Week Low

₹ 470.1

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

16186.54 Cr.

Enterprise Value

16170.94 Cr.

No. of Shares

23.93 Cr.

P/E

117.38

P/B

9.13

Face Value

₹ 2

Div. Yield

0 %

Book Value (TTM)

₹  74.12

CASH

15.6 Cr.

DEBT

0 Cr.

Promoter Holding

0 %

EPS (TTM)

₹  5.76

Sales Growth

3.97%

ROE

16.22 %

ROCE

21.41%

Profit Growth

5.91 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year3.97%
3 Year26.95%
5 Year29.94%

Profit Growth

1 Year5.91%
3 Year1.37%
5 Year22.12%

ROE%

1 Year16.22%
3 Year21.41%
5 Year41.58%

ROCE %

1 Year21.41%
3 Year28.33%
5 Year30.82%

Debt/Equity

0

Price to Cash Flow

91.86

Interest Cover Ratio

28.3636

CFO/PAT (5 Yr. Avg.)

0.788207227955418

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 0.00 0.00
Jun 2024 0.00 0.00
Mar 2024 0.00 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 26.9542336775975% for the Past 3 years.
  • Company has been maintaining healthy ROE of 21.4124666666667% over the past 3 years.
  • Company has been maintaining healthy ROCE of 28.3284% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 28.3636.
  • The Company has been maintaining an effective average operating margins of 21.7839081240511% in the last 5 years.
  • Company has a healthy liquidity position with current ratio of 3.791.

 Limitations

  • The company has shown a poor profit growth of 2.11702782377223% for the Past 3 years.
  • The company is trading at a high EV/EBITDA of 71.6877.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2024 Jun 2024 Sep 2024
Net Sales 272.5 258.6 281.7
Total Expenditure 226.1 219.1 235.3
Operating Profit 46.4 39.5 46.4
Other Income 23.1 13.7 22.4
Interest 1.5 1.5 1.6
Depreciation 7.6 6.6 6.2
Exceptional Items 0 0 0
Profit Before Tax 60.4 45.1 61
Tax 11.5 12.5 16.2
Profit After Tax 48.9 32.6 44.8
Adjusted EPS (Rs) 2.2 1.36 1.87

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 334.5 511 836.7 1005.7 1045.6
Total Expenditure 248.61 361 668 828.1 877.6
Operating Profit 85.89 150 168.7 177.6 168
Other Income 15.2 24.5 27.8 37.1 50.3
Interest 3.4 3.5 3 6.4 6.6
Depreciation 13.4 17.6 23.6 31.7 31.1
Exceptional Items -43.7 3 0 0 0
Profit Before Tax 40.59 156.4 169.9 176.6 180.6
Tax 13.8 26.9 37.2 46.4 42.7
Net Profit 31.69 132.4 132.7 130.2 137.9
Adjusted EPS (Rs.) 1.42 6.85 5.27 5.88 6.21

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 0.3 0.3 0.4 44.3 44.4
Total Reserves -3.4 253.6 649.6 751 909.4
Borrowings 315.3 0 0 0 0
Other N/C liabilities 8.1 7.1 48.8 59.4 53.2
Current liabilities 93.8 93.3 140.7 169.4 198.1
Total Liabilities 414.1 354.3 839.5 1024.1 1205.1
Assets
Net Block 9 40.6 72 78.3 56.1
Capital WIP 22.3 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 251.4 83.4 83.4 231.5 385.4
Loans & Advances 12.7 12.3 149.5 11.1 12.5
Other N/C Assets 0.2 0.1 0.1 0.3 0.1
Current Assets 118.5 217.9 534.5 702.9 751
Total Assets 414.1 354.3 839.5 1024.1 1205.1
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 40.59 159.9 169.9 176.6 180.6
Adjustment 61.3 11.3 15.5 32.8 2.5
Changes in Assets & Liabilities 2.7 -92.3 -111.3 -85.7 42.4
Tax Paid -15 -25.6 -35.9 -41.8 -49.3
Operating Cash Flow 89.5 53.3 38.2 81.9 176.2
Investing Cash Flow -51 -34.1 -266.9 -51 -189
Financing Cash Flow -18.5 -37.1 244.9 -16.9 -15.8
Net Cash Flow 20 -17.9 16.2 14 -28.6

Corporate Actions

Investors Details

 No Promoters Data available for this company.
Report us
PARTICULARS Mar 2024% Jun 2024% Sep 2024%
investors 100.00 100.00 100.00
aarabhi partners consulta... 2.11 2.11 2.11
anand kiran 2.18 2.18 2.18
bpc genesis fund i a spv ... 3.26 3.26 3.26
bpc genesis fund i spv lt... 6.29 6.29 6.29
ca dawn investments 14.52 14.52 14.52
chestnut associates (ptc)... - - 1.44
fidelity funds - india fo... - 1.17 1.62
gaurav kapoor 2.62 2.62 2.62
llp 2.11 2.29 4.34
manish gupta 8.97 8.97 8.97
nadathur fareast pte ltd 22.03 22.03 22.03
rajesh bhaskaran nair 7.13 7.13 7.13
sanjay s parikh 5.01 5.01 5.01
smallcap world fund, inc - - 1.05
sycamore associates (ptc)... - - 1.44
vida trustees private lim... - 2.34 2.34
sycamore philanthropy (pt... - 1.44 -
chestnut associates (ptc)... 1.44 - -
sycamore philanthropy (pt... 1.44 - -
vida trustees private lim... 2.34 - -

Annual Reports

No Annual reports exist for this company.Report us

Ratings & Research Reports

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Indegene Stock Price Analysis and Quick Research Report. Is Indegene an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Indegene and its performance over the period of time. Indegene stock price today is Rs 677.5.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Indegene cash from the operating activity was Rs 176.2 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Indegene has a Debt to Equity ratio of 0 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Indegene , the EPS growth was 5.6753 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Indegene has OPM of 16.0673297628156 % which is a good sign for profitability.
     
  • ROE: Indegene have a average ROE of 16.2245 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Indegene is Rs 677.5. One can use valuation calculators of ticker to know if Indegene share price is undervalued or overvalued.
Last Updated on:
Brief about Indegene
X